Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11575)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kang W, Cheng AS, Yu J, To KF. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers. World J Gastroenterol 2016; 22(3): 1279-1288 [PMID: 26811664 DOI: 10.3748/wjg.v22.i3.1279] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i3/1279.htm |
| Number | Citing Articles |
| 1 |
Li Li, Jianguo Zhao, Shanshan Huang, Yi Wang, Lingling Zhu, Yuan Cao, Jianping Xiong, Jun Deng. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway. Gene 2018; 641: 240 doi: 10.1016/j.gene.2017.09.071
|
| 2 |
Wei Kang, Tingting Huang, Yuhang Zhou, Jinglin Zhang, Raymond W. M. Lung, Joanna H. M. Tong, Anthony W. H. Chan, Bin Zhang, Chi Chun Wong, Feng Wu, Yujuan Dong, Shiyan Wang, Weiqin Yang, Yi Pan, Wing Po Chak, Alvin H. K. Cheung, Jesse C. S. Pang, Jun Yu, Alfred S. L. Cheng, Ka Fai To. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0134-0
|
| 3 |
Yan Nan Shen, In-Seon Bae, Gil Hong Park, Hwa Sik Choi, Kee-Ho Lee, Sang Hoon Kim. MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B. Biomedicine & Pharmacotherapy 2018; 105: 362 doi: 10.1016/j.biopha.2018.05.111
|
| 4 |
Shin‐Yi Chung, Wen‐Chen Huang, Zong‐Siang Chen, Ta‐Chung Chao, Yeu Su. Elucidation of the mechanism underlying CD44v6‐induced transformation of IEC‐6 normal intestinal epithelial cells. Journal of Cellular Physiology 2020; 235(1): 194 doi: 10.1002/jcp.28959
|
| 5 |
Priyanka Samji, Manoj K. Rajendran, Vidya P. Warrier, Akshayaa Ganesh, Karunagaran Devarajan. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective. Cellular Signalling 2021; 78: 109858 doi: 10.1016/j.cellsig.2020.109858
|
| 6 |
Zhen Liu, Yangyang Yao, Shanshan Huang, Li Li, Bailing Jiang, Hui Guo, Wan Lei, Jianping Xiong, Jun Deng. LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway. Biochemical and Biophysical Research Communications 2018; 505(3): 843 doi: 10.1016/j.bbrc.2018.09.191
|
| 7 |
Jinglin Zhang, Patrick M. K. Tang, Yuhang Zhou, Alfred S. L. Cheng, Jun Yu, Wei Kang, Ka Fai To. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis. Cells 2019; 8(6): 637 doi: 10.3390/cells8060637
|
| 8 |
Joo Young Kim, Eun Kyung Kim, Won Mi Lee, Young Ok Hong, Hojung Lee. VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer. APMIS 2020; 128(10): 543 doi: 10.1111/apm.13070
|
| 9 |
Zhongbo Li, Peng Su, Yinlu Ding, Honglei Gao, Huijie Yang, Xin Li, Xiao Yang, Yan Xia, Chenmiao Zhang, Mingxi Fu, Dehai Wang, Ye Zhang, Shu Zhuo, Jian Zhu, Ting Zhuang. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis. Cell Communication and Signaling 2022; 20(1) doi: 10.1186/s12964-022-00963-8
|
| 10 |
Ya‐Yun Chang, Linda Chia‐Hui Yu, I‐Shing Yu, Yu‐Lin Jhuang, Wei‐Ju Huang, Ching‐Yao Yang, Yung‐Ming Jeng. Deletion of cadherin‐17 enhances intestinal permeability and susceptibility to intestinal tumour formation. The Journal of Pathology 2018; 246(3): 289 doi: 10.1002/path.5138
|
| 11 |
Rui Jiang, Jinghua Wang, Jun Liang, Daihua Lin, Qiuxian Mao, Siyi Cheng, Shengjun Huang, Shuangshuang Tong, Yanlin lyu, Rui Wei, Qizhou Lian, Hao Chen. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1096055
|
| 12 |
Bonan Chen, Xiaoli Liu, Peiyao Yu, Fuda Xie, Johnny S. H. Kwan, Wai Nok Chan, Canbin Fang, Jinglin Zhang, Alvin H. K. Cheung, Chit Chow, Gloria W. M. Leung, Kam Tong Leung, Shihua Shi, Bin Zhang, Shouyu Wang, Dazhi Xu, Kaili Fu, Chi Chun Wong, William K. K. Wu, Michael W. Y. Chan, Patrick M. K. Tang, Chi Man Tsang, Kwok Wai Lo, Gary M. K. Tse, Jun Yu, Ka Fai To, Wei Kang. H. pylori‐induced NF‐κB‐PIEZO1‐YAP1‐CTGF axis drives gastric cancer progression and cancer‐associated fibroblast‐mediated tumour microenvironment remodelling. Clinical and Translational Medicine 2023; 13(11) doi: 10.1002/ctm2.1481
|
| 13 |
Eirini Tsirvouli, Vasundra Touré, Barbara Niederdorfer, Miguel Vázquez, Åsmund Flobak, Martin Kuiper. A Middle-Out Modeling Strategy to Extend a Colon Cancer Logical Model Improves Drug Synergy Predictions in Epithelial-Derived Cancer Cell Lines. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.502573
|
| 14 |
Anastasios Kyriazoglou, Roubini Zakopoulou, Flora Zagouri, Aristotelis Bamias, Meletios Athanasios Dimopoulos. Clinical and biological implications of Hippo pathway dysregulation in sarcomas. Forum of Clinical Oncology 2019; 9(1): 11 doi: 10.2478/fco-2018-0002
|
| 15 |
Jiyoon Jung, Jeong Won Kim, Gilhyang Kim, Joo Young Kim. Low MST1/2 and negative LATS1/2 expressions are associated with poor prognosis of colorectal cancers. Pathology - Research and Practice 2023; 248: 154608 doi: 10.1016/j.prp.2023.154608
|
| 16 |
Mouna Triki, Dorra Ben Ayed-Guerfali, Ines Saguem, Slim Charfi, Lobna Ayedi, Tahia Sellami-Boudawara, Vincent Cavailles, Raja Mokdad-Gargouri. RIP140 and LCoR expression in gastrointestinal cancers. Oncotarget 2017; 8(67): 111161 doi: 10.18632/oncotarget.22686
|
| 17 |
Zhilong Wang, Wanhang Lu, Yiling Zhang, Feng Zou, Zhigang Jin, Tiejun Zhao. The Hippo Pathway and Viral Infections. Frontiers in Microbiology 2020; 10 doi: 10.3389/fmicb.2019.03033
|
| 18 |
Tingting Huang, Yuhang Zhou, Jinglin Zhang, Chi Chun Wong, Weilin Li, Johnny S. H. Kwan, Rui Yang, Aden K. Y. Chan, Yujuan Dong, Feng Wu, Bin Zhang, Alvin H. K. Cheung, William K. K. Wu, Alfred S. L. Cheng, Jun Yu, Nathalie Wong, Wei Kang, Ka Fai To. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis. Oncogene 2018; 37(9): 1159 doi: 10.1038/s41388-017-0029-7
|
| 19 |
Liang Ge, Dong-Song Li, Fei Chen, Ji-Dong Feng, Bai Li, Tie-Jun Wang. TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells. International Journal of Oncology 2017; 51(1): 307 doi: 10.3892/ijo.2017.3998
|
| 20 |
丰 邹. Research Progress of YAP/TAZ Protein Regulating Virus Infection and Immunity. Hans Journal of Biomedicine 2021; 11(01): 8 doi: 10.12677/HJBM.2021.111002
|
| 21 |
Melissa Hum, Hock Jin Tan, Yixuan Yang, Supriya Srivastava, Ming Teh, Yoon Pin Lim. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway. The FASEB Journal 2021; 35(2) doi: 10.1096/fj.202000393R
|
| 22 |
Xubiao Nie, Zhihang Zhou, Ying Chen, Siyuan Chen, Yongyu Chen, Jing Lei, Xiaoling Wu, Song He. VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway. Digestive and Liver Disease 2024; 56(1): 187 doi: 10.1016/j.dld.2023.05.014
|
| 23 |
Dehai Wang, Zhongbo Li, Xin Li, Cheng Yan, Huijie Yang, Ting Zhuang, Xiao Wang, Yifeng Zang, Ziping Liu, Tianshi Wang, Rixia Jiang, Peng Su, Jian Zhu, Yinlu Ding. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02410-5
|
| 24 |
Joo Young Kim, You‐Na Sung, Seung‐Mo Hong. High YAP and TEAD4 immunolabelings are associated with poor prognosis in patients with gallbladder cancer. APMIS 2021; 129(12): 729 doi: 10.1111/apm.13186
|
| 25 |
Yuan Hu, Pengchuang Zhang, Yu Shi, Xuyuan Dong, Yinying Wu, Danfeng Dong, Enxiao Li, Yangwei Fan. Inhibition of Ras protein activator like 2 produces antitumor effects in gastric cancer via the suppression of YAP1 activation. Environmental Toxicology 2022; 37(3): 527 doi: 10.1002/tox.23418
|
| 26 |
Chang-Jiang Lei, Chun Yao, De-Ke Li, Zhi-Xiong Long, Yuan Li, Dan Tao, Yan-Ping Liou, Jiang-Zhou Zhang, Ning Liu. Effect of co-transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of hepatocellular carcinoma Huh7. Asian Pacific Journal of Tropical Medicine 2016; 9(9): 898 doi: 10.1016/j.apjtm.2016.07.015
|
| 27 |
Ying Chen, Guoqing Wei, Hongwei Xia, Qiulin Tang, Feng Bi. Long noncoding RNA‑ATB promotes cell proliferation, migration and invasion in gastric cancer. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8077
|
| 28 |
Yingying Liu, Yu Shi, Ruiqin Han, Chaoge Liu, Xiaogang Qin, Pengfei Li, Renjun Gu. Signaling pathways of oxidative stress response: the potential therapeutic targets in gastric cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1139589
|
| 29 |
Duanrui Liu, Yunyun Liu, Wenshuai Zhu, Yi Lu, Jingyu Zhu, Xiaoli Ma, Yuanxin Xing, Mingjie Yuan, Bin Ning, Yunshan Wang, Yanfei Jia. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo–YAP1 pathway. BMC Medicine 2023; 21(1) doi: 10.1186/s12916-023-02842-6
|
| 30 |
Suman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, Hassan Yousefi, Saikolappan Sankaralingam, Suresh K. Alahari, Sweaty Koul, Hari K. Koul. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer. Cancer Letters 2021; 507: 112 doi: 10.1016/j.canlet.2021.03.006
|
| 31 |
Fu-Yan Ma, Xi-Han Zhou, Qiao Liang. Advances in understanding of role and mechanism of Hippo signaling pathway in colorectal cancer. World Chinese Journal of Digestology 2023; 31(1): 14 doi: 10.11569/wcjd.v31.i1.14
|
| 32 |
Fariba Dehghanian, Laleh Ebrahimi Ghahnavieh, Amirhossein Naghsh Nilchi, Sheyda Khalilian, Rezvan Joonbakhsh. Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk. Gene 2024; 916: 148424 doi: 10.1016/j.gene.2024.148424
|
| 33 |
Pallaval Veera Bramhachari, Nageswara Rao Reddy Neelapu. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 3 doi: 10.1007/978-981-15-4431-6_1
|
| 34 |
Peng Cheng. A prognostic 3‐long noncoding RNA signature for patients with gastric cancer. Journal of Cellular Biochemistry 2018; 119(11): 9261 doi: 10.1002/jcb.27195
|
| 35 |
Fenfen Xiang, Mengzhe Zhang, Wenbin Hao, Rongrong Liu, Qian Li, Qing Gu, Zhaowei Zhu, Zixi Chen, Xiaoxiao Li, Xiangdong Kang, Rong Wu, Muhammad Sajid Arshad. Ursolic Acid Inhibits the Growth of Gastric Cancer by Targeting KLF4/YAP1. Journal of Food Biochemistry 2023; 2023: 1 doi: 10.1155/2023/7729962
|
| 36 |
Yu Li, Lan Li, Min Zhu, Limin Ye, Qian Yang. Upregulation of Yes-associated protein and transcriptional co-activator with PDZ-binding motif influences the behavior of LOVO human colon adenocarcinoma cells. Experimental and Therapeutic Medicine 2017; 14(4): 3831 doi: 10.3892/etm.2017.4962
|
| 37 |
Wenhui Zheng, Junbin Lan, Lihua Feng, Zuhong Chen, Shuitu Feng, Yingqin Gao, Fang Ren, Yide Chen. Structure-Based Optimization of Conformationally Constrained Peptides to Target Esophageal Cancer TEAD Transcription Factor. International Journal of Peptide Research and Therapeutics 2021; 27(2): 923 doi: 10.1007/s10989-020-10138-z
|
| 38 |
Chongchong Wang, Li Cheng. Gankyrin as a potential therapeutic target for cancer. Investigational New Drugs 2017; 35(5): 655 doi: 10.1007/s10637-017-0474-8
|
| 39 |
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian. Flaming the fight against cancer cells: the role of microRNA-93. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01349-x
|
| 40 |
Donglei Zhang, Hongna Wu, Jing Zhao. Computational design and experimental substantiation of conformationally constrained peptides from the complex interfaces of transcriptional enhanced associate domains with their cofactors in gastric cancer. Computational Biology and Chemistry 2021; 94: 107569 doi: 10.1016/j.compbiolchem.2021.107569
|
| 41 |
Zijun Guo, Lin Guo. Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression. International Journal of Clinical Oncology 2024; 29(4): 442 doi: 10.1007/s10147-024-02478-3
|
| 42 |
Pavani Sanapala, Sudhakar Pola. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 221 doi: 10.1007/978-981-15-4431-6_13
|
| 43 |
Kai Niu, Yanling Liu, Zijun Zhou, Xuefeng Wu, Huaiwu Wang, Jingzhe Yan, Guido Bocci. Antitumor Effects of Paeoniflorin on Hippo Signaling Pathway in Gastric Cancer Cells. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/4724938
|
| 44 |
Zi Liang, Yahong Lu, Mengsheng Jiang, Ying Qian, Liyuan Zhu, Sulan Kuang, Fei Chen, Yongjie Feng, Xiaolong Hu, Guangli Cao, Renyu Xue, Chengliang Gong. Alternative isoforms of BmYki have different transcriptional co-activator activity in the silkworm, Bombyx mori. The International Journal of Biochemistry & Cell Biology 2019; 116: 105599 doi: 10.1016/j.biocel.2019.105599
|
| 45 |
Tao An, Yanting Lu, Zhaoqi Gong, Yongtao Wang, Chen Su, Guimei Tang, Jingjing Hou. Research Progress for Targeting Deubiquitinases in Gastric Cancers. Cancers 2022; 14(23): 5831 doi: 10.3390/cancers14235831
|
| 46 |
Kaveh Baghaei, Nazanin Hosseinkhan, Hamid Asadzadeh Aghdaei, M. R. Zali. Investigation of a common gene expression signature in gastrointestinal cancers using systems biology approaches. Molecular BioSystems 2017; 13(11): 2277 doi: 10.1039/C7MB00450H
|
| 47 |
Eojin Kim, Bokyung Ahn, Harim Oh, Yoo Jin Lee, Jeong Hyeon Lee, Youngseok Lee, Chul Hwan Kim, Yang-Seok Chae, Joo Young Kim. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer. Pathology 2019; 51(3): 261 doi: 10.1016/j.pathol.2019.01.001
|
| 48 |
XiaoPeng Wang, Mo Zhu, Hao Zuo, Guowei Hou, Rui Xie. ADAM Metallopeptidase Domain 12 Facilitates Colorectal Cancer Progression by Inhibiting Hippo Signaling Pathway Activity. Molecular Cancer Research 2023; 21(6): 525 doi: 10.1158/1541-7786.MCR-22-0384
|
| 49 |
Yuhang Zhou, Jinglin Zhang, Hui Li, Tingting Huang, Chi Chun Wong, Feng Wu, Man Wu, Nuoqing Weng, Liping Liu, Alfred S. L. Cheng, Jun Yu, Nathalie Wong, Kwok Wai Lo, Patrick M. K. Tang, Wei Kang, Ka Fai To. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis. Oncogene 2020; 39(22): 4375 doi: 10.1038/s41388-020-1293-5
|
| 50 |
Shuxia Gao, Yingchao Wang, Lijuan Ji. Rational design and chemical modification of TEAD coactivator peptides to target hippo signaling pathway against gastrointestinal cancers. Journal of Receptors and Signal Transduction 2021; 41(4): 408 doi: 10.1080/10799893.2020.1818093
|
| 51 |
Rogayeh Soltani, Mohammad Amini, Marziyeh Mazaheri Moghaddam, Asiyeh Jebelli, Sahar Ahmadiyan, Negar Bidar, Behzad Baradaran, Habib MotieGhader, Milad Asadi, Ahad Mokhtarzadeh. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target. Molecular Biology Reports 2022; 49(7): 6817 doi: 10.1007/s11033-021-07038-w
|
| 52 |
Xue Zhen Wang, Lei Xia, Xiao Yu Zhang, Qian Chen, Xiao Li, Yue Mou, Tong Wang, Ya Nan Zhang. The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art. Biomedicine & Pharmacotherapy 2022; 149: 112800 doi: 10.1016/j.biopha.2022.112800
|
| 53 |
Peng Zhang, Dongyi Liu, Yifeng Zang, Jinqing Wang, Ziping Liu, Jian Zhu, Xin Li, Yinlu Ding. USP12 facilitates gastric cancer progression via stabilizing YAP. Cell Death Discovery 2024; 10(1) doi: 10.1038/s41420-024-01943-2
|
| 54 |
Honghao Sheng, Leiming You, Xiaopu Sang, Xinhui Gao, Aijie Liu, Ting'an Li, Kunyu Li, Shen Zhang, Guangrui Huang, Ting Wang, Anlong Xu. Screening for blood leukocyte microRNA biomarkers responsible for association between qi deficiency constitution and Pi-qi-deficiency syndrome of chronic superficial gastritis. Journal of Traditional Chinese Medical Sciences 2018; 5(4): 335 doi: 10.1016/j.jtcms.2018.11.003
|
| 55 |
Soon Auck Hong, Myoung Won Son, Junhun Cho, Si‐hyong Jang, Hyun Ju Lee, Ji‐Hye Lee, Hyun Deuk Cho, Mee‐Hye Oh, Moon Soo Lee. Low angiomotin‐p130 with concomitant high Yes‐associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer. APMIS 2017; 125(11): 996 doi: 10.1111/apm.12750
|